Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.39 |
| ▸ | CFTR | P13569 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.37 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.37 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.37 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| L-Kynurenine SCHEMBL9636977 | 0.93 | KDM4E (0.49) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL3501286 | 0.85 | ALDH1A1 (0.40) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL5388881 | 0.83 | MAPT (0.43) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL288333 | 0.83 | MAPT (0.43) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL19273911 | 0.82 | GAA (0.46) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL4996617 | 0.82 | MAPT (0.42) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL18796376 | 0.82 | GAA (0.46) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL1331881 | 0.82 | KMT2A (0.40) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL29922241 | 0.81 | ALDH1A1 (0.38) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL9242281 | 0.79 | MAPT (0.40) | KDM4EALDH1A1MAPTGAAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2268 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4667453-A1 | METHOD FOR PRODUCING TRYPTOPHAN DECOMPOSITION PRODUCT, METHOD FOR PRODUCING FORMYLKYNURENINE, METHOD FOR PRODUCING KYNURENINE, METHOD FOR PRODUCING TRYPTOPHANRADICALS-CONTAINING AQUEOUS SOLUTION, AND BACTERICIDAL AQUEOUS SOLUTION | NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP) | 2025-12-24 | — | — | EP | claimed |
| EP-4648788-A1 | LIPID BINDING PROTEIN MOLECULE THERAPY | Abionyx Pharma SA (FR) | 2025-11-19 | — | — | EP | claimed |
| EP-3831379-B1 | A COMPOSITION CONTAINING NICOTINIC ACID AND/OR NICOTINAMIDE AND/OR TRYPTOPHAN FOR POSITIVELY INFLUENCING THE INTESTINAL MICROBIOTA | CONARIS RES INSTITUTE AG (DE) | 2025-09-10 | — | — | EP | claimed |
| US-20250213549-A1 | COMPOSITION COMPRISING NICOTINAMIDE, NICOTINAMIDE PRECURSORS, NICOTINAMIDE METABOLITES OR COMBINATIONS THEREOF FOR PREVENTING OR REDUCING ONE OR MORE POST-ACUTE SYMPTOMS OF INFECTIOUS DISEASES | CONARIS RESEARCH INSTITUTE AG (DE) | 2025-07-03 | — | — | US | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| CN-114938659-B | Cardiovascular disease onset risk assessment marker based on metabonomics data and application thereof | 中国医学科学院阜外医院 | 2025-03-04 | — | — | CN | claimed |
| WO-2024150064-A9 | LIPID BINDING PROTEIN MOLECULE THERAPY | ABIONYX PHARMA SA (FR) | 2025-02-20 | — | — | WO | claimed |
| CN-119391580-A | Lactobacillus rhamnosus capable of preventing or treating inflammatory bowel disease and promoting digestion and application thereof | 内蒙古科拓生物有限公司 | 2025-02-07 | — | — | CN | claimed |
| EP-4499059-A1 | COMPOSITION COMPRISING NICOTINAMIDE, NICOTINAMIDE PRECURSORS, NICOTINAMIDE METABOLITES OR COMBINATIONS THEREOF FOR PREVENTING OR REDUCING ONE OR MORE POST-ACUTE SYMPTOMS OF INFECTIOUS DISEASES | CONARIS research institute AG (DE) | 2025-02-05 | — | — | EP | claimed |
| US-12103960-B2 | VEGF traps and mini-traps and methods for treating ocular disorders and cancer | REGENERON PHARMACEUTICALS, INC. (US) | 2024-10-01 | — | — | US | claimed |
| US-20110300142-A1 | USE OF ZEBURALINE FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR IMMUNE REJECTION OF TRANSPLANTS | IDOGEN AB (SE) | 2011-12-08 | — | — | US | claimed |
| US-20100261774-A1 | Methods for the modulation of Leishmania major infection in mammals | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2010-10-14 | — | — | US | claimed |
| EP-2164500-A1 | THE USE OF ZEBURALINE FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR IMMUNE REJECTION OF TRANSPLANTS | Idogen AB (SE) | 2010-03-24 | — | — | EP | claimed |
| US-20090208565-A1 | STABILIZED EXENDIN-4 COMPOUNDS | ZEALAND PHARMA A/S (DK) | 2009-08-20 | — | — | US | claimed |
| WO-2008147283-A1 | THE USE OF ZEBURALINE FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR IMMUNE REJECTION OF TRANSPLANTS | SALFORD LEIF (SE) | 2008-12-04 | — | — | WO | claimed |
| US-20080090223-A1 | Method for Diagnosing Hepatic Diseases | PROYECTO DE BIOMEDICINA CIMA, S.L. (ES) | 2008-04-17 | — | — | US | claimed |
| US-20060194719-A1 | Stabilized exendin-4 compounds | ZEALAND PHARMA A/S (DK) | 2006-08-31 | — | — | US | claimed |
| EP-1546200-A2 | STABILIZED EXENDIN-4 COMPOUNDS | Zealand Pharma A/S (DK) | 2005-06-29 | — | — | EP | claimed |
| WO-2004035623-A2 | STABILIZED EXENDIN-4 COMPOUNDS | ZEALAND PHARMA A/S (DK) | 2004-04-29 | — | — | WO | claimed |
| EP-1369114-A1 | Use of tryptophan metabolites as pharmaceutical agents | Terness, Peter, Priv. Doz. Dr. (DE) | 2003-12-10 | — | — | EP | claimed |